Matthew Meyerson among first class of recipients of NCI Outstanding Investigator Award

Matthew Meyerson was awarded a prestigious Outstanding Investigator Award (R35 grant) from the National Cancer Institute, effective August 2015 through June 2022. He is one of about 40 scientists nationwide to receive this 7-year research grant, in recognition of his groundbreaking contributions to lung cancer research and of the potential of his research program to continue to engineer genomics-driven breakthroughs in lung cancer biology.